NCT01919879 2018-05-08Dual Targeting of EGFR With Cetuximab and Afatinib to Treat Refractory wtKRAS Metastatic Colorectal CancerUNICANCERPhase 2 Completed75 enrolled
NCT00801294 2017-12-29A Phase II Trial of Weekly Alternating Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Advanced Colorectal CancerBoehringer IngelheimPhase 2 Completed46 enrolled